Your browser is not up to date and is not able to run this publication.
Learn more

FEBRUARY 2018

LAUNCH OF THE INSIDE LVMH PROGRAM

In February 2018, the LVMH Group launched the Inside LVMH program, a unique digital experience for students from Europe s top 50 schools and universities and for Group interns. The program allows talented young people to deepen their understanding of the strategic challenges in the luxury industry and Imagine the Luxury Experience of Tomorrow . In all, more than 4,400 talented young participants joined the program. Of the 200 short-listed students, three winning teams had the opportunity to present their ideas at the LVMH Group s headquarters in Paris, with LVMH Chairman and CEO Bernard Arnault in attendance, along with 50 members of the Group s top management, including Maison Presidents and members of the LVMH Executive Committee. This initiative reflects the Group s ambition to identify the next generation of international talent and bridge the gap between the academic and professional worlds.

SOCIETY & THE ENVIRONMENT

Since its inception, the Group has made sustainable development one of its strategic priorities. This policy provides a powerful response to the issues of corporate ethical responsibility in general, as well as the role a group like LVMH should play within French society and internationally.

DECEMBER 2018

SIXTH ANNUAL LVMH ENGAGED MAISONS DINNER

On December 5, 2018, LVMH s sixth annual Engaged Maisons Dinner was held at the Palais Brongniart. This annual event celebrates the Group and its Maisons com- mitment to humanitarian causes and partnership with nonprofits such as UNICEF, Belle & Bien, Cancer@Work, ELA, Epic Foundation, ESAT de L Arche, Force Femmes, Kelina, Les Restos du Cœur, Les Virades de l Espoir, Save the Children and Toutes à l École. The Group supports these organizations all year round and raises funds for the fight against sickle-cell anemia at this event. Alongside the staff of Robert-Debré Hospital in Paris, LVMH and its Maisons help battle this disease by funding research and patient treatment.